ERBB2 and breast cancer: It is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2 receptor 2, HER-2) expression and accounts for 10–20% of all breast cancers [1].